
The zzso target of zzso zzso is an zzso zzso protein zzso positioned at a central point in a variety of cellular signaling zzso The established involvement of zzso activity in the cellular processes that contribute to the development and progression of cancer has identified zzso as a major link in zzso zzso zzso of zzso including zzso zzso and zzso (formerly zzso have been developed and assessed for their safety and efficacy in patients with zzso zzso is an zzso administered agent approved by the US Food and Drug Administration zzso and the European zzso Agency zzso for the treatment of advanced zzso cell zzso zzso zzso is an oral agent that has recently obtained US zzso and zzso approval for the treatment of advanced zzso after failure of treatment with zzso or zzso zzso is not yet approved for any zzso The use of zzso zzso either alone or in combination with other zzso agents, has the potential to provide zzso activity in numerous tumor zzso Cancer types in which these agents are under evaluation include neuroendocrine tumors, breast cancer, zzso lymphoma, zzso zzso gastric cancer, pancreatic cancer, zzso zzso cancer, and zzso lung zzso The results of ongoing clinical trials with zzso zzso as single agents and in combination regimens, will better define their activity in zzso 

